Company information:
Calcico Therapeutics Limited (No: 07948431)
Address: ADVENT LIFE SCIENCES LTD 158-160, NORTH GOWER STREET, LONDON, NW1 2ND, ENGLAND
Status: Active
Incorporated: 14-Feb-2012
Accounts Next Due: 30-Sep-2020
Next Confirmation Statement Due: 28-Feb-2021
Industry Class: 72110 - Research and experimental development on biotechnology
Current Director: IP2IPO SERVICES LTD ( From: Apr-2018 )
Current Director: MOHAMMED SHAHZAD AHMED MALIK ( DOB: Mar-1967 From: Feb-2012 )
Resigned Director: MAINA BHAMAN ( DOB: Feb-1972 From: May-2015 To: Dec-2017 )
Resigned Director: MARY FRANCES FITZGERALD ( From: Jan-2017 To: Sep-2017 )
Resigned Director: DANIEL BACH GONZALEZ ( From: Dec-2017 To: Apr-2018 )
Resigned Director: DAYLE SPENCER HOGG ( DOB: Mar-1976 From: Feb-2013 To: May-2015 )
Resigned Director: ANANT PAREKH ( From: Dec-2012 To: Oct-2018 )
Resigned Director: ROBERTO CELESTE ERCOLE SOLARI ( DOB: Nov-1956 From: Nov-2016 To: Aug-2019 )
Resigned Director: ANDREW JOHN WOOD ( DOB: Oct-1955 From: Mar-2012 To: Oct-2018 )
Persons of Significant Control:
Touchstone Innovations Businesses Llp, 52 Princes Gate, Exhibition Road, London, SW7 2PG, England: Ownership of shares – More than 25% but not more than 50%, Ownership of voting rights - More than 25% but not more than 50% (Notified: 2016-04-06)
Advent Life Sciences Llp, 52 Princes Gate, Exhibition Road, London, SW7 2PG, England: Ownership of shares – More than 25% but not more than 50%, Ownership of voting rights - More than 25% but not more than 50% (Notified: 2016-04-06)